Becker's Healthcare November 18, 2024
Rylee Wilson

The Drug Enforcement Administration will extend rules allowing providers to prescribe controlled substances via telehealth through the end of 2025.

In a news release published Nov. 15, the agency says it is “continuing to consider” feedback it received on telehealth prescribing rules and is working toward a final rule.

During the COVID-19 pandemic, the DEA implemented several telehealth flexibilities, including allowing prescribing of controlled substances. Before the pandemic, patients were required to have at least one in-person visit with a provider before they could receive controlled substances via telehealth.

Here are three things for behavioral health leaders to note:

  1. Proponents of the policy argue telehealth increases access to medication-assisted treatment for opioid use disorder treatment...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Govt Agencies, Mental Health, Patient / Consumer, Provider, Technology, Telehealth
Teledermatology Improves Outcomes and Reduces Costs | AAD 2025
The Basics of Teledermatology | AAD 2025
Telehealth: What’s at stake?
The “New” New Normal: Changes in Telemedicine Utilization Since COVID-19
New Zealand to launch new 24/7 telehealth

Share This Article